OLIDIA references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.
Olidia 240
Olidia 240 is an injectable, sterile absorbable poly-L-lactic acid (PLLA) dermal filler by PRP Life Science Co., Ltd. in South Korea, created for the temporary improvement of moderate to severe nasolabial folds. It is suitable for professionals who administer it by injection into the deep dermis or the subcutaneous (subdermal) layer. The formulation combines PLLA with carboxymethylcellulose (CMC) and mannitol at a dose of 243.4 mg per vial and is intended for professional use.
主なメリット: Olidia 240
- Improves moderate to severe nasolabial folds
- PLLA-based formulation designed for a gradual tissue response after injection
- For professional injection into the deep dermis or subdermal layer
- CE-marked medical device (CE 1434)
適応と専門的な使用
主な適応
- Moderate to severe nasolabial folds
専門的な使用
For professional use only, by trained physicians. Olidia 240 is administered by injection into the deep dermis or subdermal layer to temporarily improve moderate to severe nasolabial folds. Ensure the product is sterile before use and check the expiration date on the product label. Explain the indications, contraindications, and potential side effects to the patient prior to treatment. Avoid areas where vascular occlusion may occur; injection into blood vessels may cause serious effects including blindness, so avoid areas of thin skin and high vascularity such as the glabella and periorbital areas. Do not inject into the vermilion of the lips; safety and efficacy for lip augmentation are not established.
施術部位
- Moderate to severe nasolabial folds.
対象となる患者
Do not use until any infection or inflammation at or near the injection site is resolved. Do not use in patients hypersensitive to the product or its components. Safety has not been established in patients susceptible to keloids, hyperpigmentation, or hypertrophic scarring. In patients with a history of herpetic eruption, injection may trigger recurrence.
作用の仕組み: Olidia 240
Olidia 240 works through poly-L-lactic acid (PLLA) combined with carboxymethylcellulose and mannitol. Injected into the deep dermis or subdermal layer, the PLLA stimulates a gradual tissue response to temporarily improve moderate to severe nasolabial folds.
Allparaで注文する理由
Allparaは、正規品で検証済みの OLIDIA 製品を厳選されたサプライヤーから提供し、完全なロットトレーサビリティと専門家によるサポートを備えています。CE認証製品、EU倉庫からのEU全域への迅速な配送、競争力のある業務用価格で、クリニックと美容医療の専門家にサービスを提供しています。私たちが重視するのは患者様の安全、満足、そして結果です。安心してご利用いただけるよう、専任のアフターサポートをご用意しています。
よくある質問
What is Olidia 240 used for?
Olidia 240 is used to temporarily improve moderate to severe nasolabial folds.
What is in the Olidia 240 formula?
Olidia 240 contains poly-L-lactic acid (PLLA) with carboxymethylcellulose (CMC) and mannitol, at a dose of 243.4 mg per vial.
Where is Olidia 240 injected?
Olidia 240 is injected into the deep dermis or subdermal layer.
その他の製品: PRP Life Science
Clinic alternatives
Pick up where you left off
Olidia 240
Olidia 240 is an injectable, sterile absorbable poly-L-lactic acid (PLLA) dermal filler by PRP Life Science Co., Ltd. in South Korea, created for the temporary improvement of moderate to severe nasolabial folds. It is suitable for professionals who administer it by injection into the deep dermis or the subcutaneous (subdermal) layer. The formulation combines PLLA with carboxymethylcellulose (CMC) and mannitol at a dose of 243.4 mg per vial and is intended for professional use.
主なメリット: Olidia 240
- Improves moderate to severe nasolabial folds
- PLLA-based formulation designed for a gradual tissue response after injection
- For professional injection into the deep dermis or subdermal layer
- CE-marked medical device (CE 1434)
適応と専門的な使用
主な適応
- Moderate to severe nasolabial folds
専門的な使用
For professional use only, by trained physicians. Olidia 240 is administered by injection into the deep dermis or subdermal layer to temporarily improve moderate to severe nasolabial folds. Ensure the product is sterile before use and check the expiration date on the product label. Explain the indications, contraindications, and potential side effects to the patient prior to treatment. Avoid areas where vascular occlusion may occur; injection into blood vessels may cause serious effects including blindness, so avoid areas of thin skin and high vascularity such as the glabella and periorbital areas. Do not inject into the vermilion of the lips; safety and efficacy for lip augmentation are not established.
施術部位
- Moderate to severe nasolabial folds.
対象となる患者
Do not use until any infection or inflammation at or near the injection site is resolved. Do not use in patients hypersensitive to the product or its components. Safety has not been established in patients susceptible to keloids, hyperpigmentation, or hypertrophic scarring. In patients with a history of herpetic eruption, injection may trigger recurrence.
作用の仕組み: Olidia 240
Olidia 240 works through poly-L-lactic acid (PLLA) combined with carboxymethylcellulose and mannitol. Injected into the deep dermis or subdermal layer, the PLLA stimulates a gradual tissue response to temporarily improve moderate to severe nasolabial folds.
Allparaで注文する理由
Allparaは、正規品で検証済みの OLIDIA 製品を、完全なロットトレーサビリティ、CE認証在庫、EU全域への迅速な配送、専門的なアフターサポートとともに提供しています。
よくある質問
What is Olidia 240 used for?
Olidia 240 is used to temporarily improve moderate to severe nasolabial folds.
What is in the Olidia 240 formula?
Olidia 240 contains poly-L-lactic acid (PLLA) with carboxymethylcellulose (CMC) and mannitol, at a dose of 243.4 mg per vial.
Where is Olidia 240 injected?
Olidia 240 is injected into the deep dermis or subdermal layer.